Cargando…

Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives

PURPOSE: Precision oncology, such as next generation sequencing (NGS) molecular analysis and bioinformatics are used to guide targeted therapies. The laboratory turnaround time (TAT) is a key performance indicator of laboratory performance. This study aims to formally apply statistical process contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Sneha Rajiv, Sim, Wilson, Ng, Cheng Han, Chin, Yip Han, Lim, Wen Hui, Syn, Nicholas L., Kamal, Nur Haidah Bte Ahmad, Gupta, Mehek, Heong, Valerie, Lee, Xiao Wen, Sapari, Nur Sabrina, Koh, Xue Qing, Isa, Zul Fazreen Adam, Ho, Lucius, O’Hara, Caitlin, Ulagapan, Arvindh, Gu, Shi Yu, Shroff, Kashyap, Weng, Rei Chern, Lim, Joey S. Y., Lim, Diana, Pang, Brendan, Ng, Lai Kuan, Wong, Andrea, Soo, Ross Andrew, Yong, Wei Peng, Chee, Cheng Ean, Lee, Soo-Chin, Goh, Boon-Cher, Soong, Richie, Tan, David S.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498582/
https://www.ncbi.nlm.nih.gov/pubmed/34631570
http://dx.doi.org/10.3389/fonc.2021.736265
_version_ 1784580194569289728
author Jain, Sneha Rajiv
Sim, Wilson
Ng, Cheng Han
Chin, Yip Han
Lim, Wen Hui
Syn, Nicholas L.
Kamal, Nur Haidah Bte Ahmad
Gupta, Mehek
Heong, Valerie
Lee, Xiao Wen
Sapari, Nur Sabrina
Koh, Xue Qing
Isa, Zul Fazreen Adam
Ho, Lucius
O’Hara, Caitlin
Ulagapan, Arvindh
Gu, Shi Yu
Shroff, Kashyap
Weng, Rei Chern
Lim, Joey S. Y.
Lim, Diana
Pang, Brendan
Ng, Lai Kuan
Wong, Andrea
Soo, Ross Andrew
Yong, Wei Peng
Chee, Cheng Ean
Lee, Soo-Chin
Goh, Boon-Cher
Soong, Richie
Tan, David S.P.
author_facet Jain, Sneha Rajiv
Sim, Wilson
Ng, Cheng Han
Chin, Yip Han
Lim, Wen Hui
Syn, Nicholas L.
Kamal, Nur Haidah Bte Ahmad
Gupta, Mehek
Heong, Valerie
Lee, Xiao Wen
Sapari, Nur Sabrina
Koh, Xue Qing
Isa, Zul Fazreen Adam
Ho, Lucius
O’Hara, Caitlin
Ulagapan, Arvindh
Gu, Shi Yu
Shroff, Kashyap
Weng, Rei Chern
Lim, Joey S. Y.
Lim, Diana
Pang, Brendan
Ng, Lai Kuan
Wong, Andrea
Soo, Ross Andrew
Yong, Wei Peng
Chee, Cheng Ean
Lee, Soo-Chin
Goh, Boon-Cher
Soong, Richie
Tan, David S.P.
author_sort Jain, Sneha Rajiv
collection PubMed
description PURPOSE: Precision oncology, such as next generation sequencing (NGS) molecular analysis and bioinformatics are used to guide targeted therapies. The laboratory turnaround time (TAT) is a key performance indicator of laboratory performance. This study aims to formally apply statistical process control (SPC) methods such as CUSUM and EWMA to a precision medicine programme to analyze the learning curves of NGS and bioinformatics processes. PATIENTS AND METHODS: Trends in NGS and bioinformatics TAT were analyzed using simple regression models with TAT as the dependent variable and chronologically-ordered case number as the independent variable. The M-estimator “robust” regression and negative binomial regression were chosen to serve as sensitivity analyses to each other. Next, two popular statistical process control (SPC) approaches which are CUSUM and EWMA were utilized and the CUSUM log-likelihood ratio (LLR) charts were also generated. All statistical analyses were done in Stata version 16.0 (StataCorp), and nominal P < 0.05 was considered to be statistically significant. RESULTS: A total of 365 patients underwent successful molecular profiling. Both the robust linear model and negative binomial model showed statistically significant reductions in TAT with accumulating experience. The EWMA and CUSUM charts of overall TAT largely corresponded except that the EWMA chart consistently decreased while the CUSUM analyses indicated improvement only after a nadir at the 82(nd) case. CUSUM analysis found that the bioinformatics team took a lower number of cases (54 cases) to overcome the learning curve compared to the NGS team (85 cases). CONCLUSION: As NGS and bioinformatics lead precision oncology into the forefront of cancer management, characterizing the TAT of NGS and bioinformatics processes improves the timeliness of data output by potentially spotlighting problems early for rectification, thereby improving care delivery.
format Online
Article
Text
id pubmed-8498582
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84985822021-10-09 Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives Jain, Sneha Rajiv Sim, Wilson Ng, Cheng Han Chin, Yip Han Lim, Wen Hui Syn, Nicholas L. Kamal, Nur Haidah Bte Ahmad Gupta, Mehek Heong, Valerie Lee, Xiao Wen Sapari, Nur Sabrina Koh, Xue Qing Isa, Zul Fazreen Adam Ho, Lucius O’Hara, Caitlin Ulagapan, Arvindh Gu, Shi Yu Shroff, Kashyap Weng, Rei Chern Lim, Joey S. Y. Lim, Diana Pang, Brendan Ng, Lai Kuan Wong, Andrea Soo, Ross Andrew Yong, Wei Peng Chee, Cheng Ean Lee, Soo-Chin Goh, Boon-Cher Soong, Richie Tan, David S.P. Front Oncol Oncology PURPOSE: Precision oncology, such as next generation sequencing (NGS) molecular analysis and bioinformatics are used to guide targeted therapies. The laboratory turnaround time (TAT) is a key performance indicator of laboratory performance. This study aims to formally apply statistical process control (SPC) methods such as CUSUM and EWMA to a precision medicine programme to analyze the learning curves of NGS and bioinformatics processes. PATIENTS AND METHODS: Trends in NGS and bioinformatics TAT were analyzed using simple regression models with TAT as the dependent variable and chronologically-ordered case number as the independent variable. The M-estimator “robust” regression and negative binomial regression were chosen to serve as sensitivity analyses to each other. Next, two popular statistical process control (SPC) approaches which are CUSUM and EWMA were utilized and the CUSUM log-likelihood ratio (LLR) charts were also generated. All statistical analyses were done in Stata version 16.0 (StataCorp), and nominal P < 0.05 was considered to be statistically significant. RESULTS: A total of 365 patients underwent successful molecular profiling. Both the robust linear model and negative binomial model showed statistically significant reductions in TAT with accumulating experience. The EWMA and CUSUM charts of overall TAT largely corresponded except that the EWMA chart consistently decreased while the CUSUM analyses indicated improvement only after a nadir at the 82(nd) case. CUSUM analysis found that the bioinformatics team took a lower number of cases (54 cases) to overcome the learning curve compared to the NGS team (85 cases). CONCLUSION: As NGS and bioinformatics lead precision oncology into the forefront of cancer management, characterizing the TAT of NGS and bioinformatics processes improves the timeliness of data output by potentially spotlighting problems early for rectification, thereby improving care delivery. Frontiers Media S.A. 2021-09-24 /pmc/articles/PMC8498582/ /pubmed/34631570 http://dx.doi.org/10.3389/fonc.2021.736265 Text en Copyright © 2021 Jain, Sim, Ng, Chin, Lim, Syn, Kamal, Gupta, Heong, Lee, Sapari, Koh, Isa, Ho, O’Hara, Ulagapan, Gu, Shroff, Weng, Lim, Lim, Pang, Ng, Wong, Soo, Yong, Chee, Lee, Goh, Soong and Tan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Jain, Sneha Rajiv
Sim, Wilson
Ng, Cheng Han
Chin, Yip Han
Lim, Wen Hui
Syn, Nicholas L.
Kamal, Nur Haidah Bte Ahmad
Gupta, Mehek
Heong, Valerie
Lee, Xiao Wen
Sapari, Nur Sabrina
Koh, Xue Qing
Isa, Zul Fazreen Adam
Ho, Lucius
O’Hara, Caitlin
Ulagapan, Arvindh
Gu, Shi Yu
Shroff, Kashyap
Weng, Rei Chern
Lim, Joey S. Y.
Lim, Diana
Pang, Brendan
Ng, Lai Kuan
Wong, Andrea
Soo, Ross Andrew
Yong, Wei Peng
Chee, Cheng Ean
Lee, Soo-Chin
Goh, Boon-Cher
Soong, Richie
Tan, David S.P.
Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives
title Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives
title_full Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives
title_fullStr Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives
title_full_unstemmed Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives
title_short Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives
title_sort statistical process control charts for monitoring next-generation sequencing and bioinformatics turnaround in precision medicine initiatives
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498582/
https://www.ncbi.nlm.nih.gov/pubmed/34631570
http://dx.doi.org/10.3389/fonc.2021.736265
work_keys_str_mv AT jainsneharajiv statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT simwilson statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT ngchenghan statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT chinyiphan statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT limwenhui statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT synnicholasl statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT kamalnurhaidahbteahmad statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT guptamehek statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT heongvalerie statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT leexiaowen statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT saparinursabrina statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT kohxueqing statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT isazulfazreenadam statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT holucius statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT oharacaitlin statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT ulagapanarvindh statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT gushiyu statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT shroffkashyap statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT wengreichern statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT limjoeysy statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT limdiana statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT pangbrendan statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT nglaikuan statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT wongandrea statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT soorossandrew statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT yongweipeng statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT cheechengean statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT leesoochin statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT gohbooncher statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT soongrichie statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives
AT tandavidsp statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives